The expression of murine eutaneous late phase reaction requires both IgE antibodies and CD4 T eells
K Sawada, H Nagai, Y Basaki… - Clinical & …, 1997 - Wiley Online Library
K Sawada, H Nagai, Y Basaki, H Yamaya, K Ikizawa, M Watanabe, M Kojima, N Matsuura…
Clinical & Experimental Allergy, 1997•Wiley Online LibraryBackground Exposure of atopic patients to a specific allergen evokes an immediate
response which is followed, in many cases, by a late phase reaction (LPR) some hours later.
Here we have examined the immunological mechanisms required for the expression of
cutaneous LPR in mice. Methods BALB/c mice were immunized by ip injection of ovalbumin
(OVA) and alum actively or by iv injection of anti‐OVA IgE monoclonal antibody (mAb)
passively. After challenge by intradermal injection of OVA into ears, the changes in ear …
response which is followed, in many cases, by a late phase reaction (LPR) some hours later.
Here we have examined the immunological mechanisms required for the expression of
cutaneous LPR in mice. Methods BALB/c mice were immunized by ip injection of ovalbumin
(OVA) and alum actively or by iv injection of anti‐OVA IgE monoclonal antibody (mAb)
passively. After challenge by intradermal injection of OVA into ears, the changes in ear …
Summary
Background Exposure of atopic patients to a specific allergen evokes an immediate response which is followed, in many cases, by a late phase reaction (LPR) some hours later. Here we have examined the immunological mechanisms required for the expression of cutaneous LPR in mice.
Methods BALB/c mice were immunized by i.p. injection of ovalbumin (OVA) and alum actively or by i.v. injection of anti‐OVA IgE monoclonal antibody (mAb) passively. After challenge by intradermal injection of OVA into ears, the changes in ear thickness, the number of eosinophils, and the levels of IL4 and IFN‐γ protein at the site of antigen challenge were examined.
Results Actively immunized mice developed a biphasic response at the site of OVA injection, while mice passively immunized with IgE anti‐OVA mAb displayed a strong early response but no LPR. Cell transfer experiments using BALB/c nu/nu mice revealed that both OVA‐specific IgE mAb and OVA‐primed CD4 T cells were required to evoke LPR. Moreover, LPR was associated with increased levels of IL‐4 production concomitant with reduced IFN‐γ production and was abolished by pretreatment with anti‐IL‐4 neutralizing mAb.
Conclusion It is suggested that murine cutaneous LPR against OVA is a type 2 inflammatory response in which both IgH antibodies and CD4 T cells play an obligatory role.
Wiley Online Library